QTXB

QuantRx Biomedical Corporation QTXB

Trading inactive

Individual Beneficiary

Name of reporting person Citizenship or organization Sole voting power Shared voting power Sole dispositive power Shared dispositive power Amount beneficially owned Percent of class Accepted date
Matthew Balk United States 4798025 0 4798025 0 4798025 9.5 % 17/02/2012
Jason T. Adelman United States 0 5032107 0 5032107 5032107 9.98 % 15/02/2012

Senat trading

Bureau Date de la transaction Date de réception Type Amount Commentaire

Senat Divulgation

Représentant Date de la transaction Date de divulgation Type Amount District